You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Keynote

Showing 376 - 398 of 398
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Melanoma Trial in Japan (Combination of GEN0101 and Pembrolizmub)

Unknown status
  • Advanced Melanoma
  • Combination of GEN0101 and Pembrolizmub
  • Nagoya, Aichi, Japan
  • +6 more
Jan 27, 2019

Stage IV NSCLC Trial in Worldwide (Necitumumab, Pembrolizumab)

Completed
Has Results
  • Stage IV Non-Small Cell Lung Cancer
  • Fort Myers, Florida
  • +15 more
Sep 11, 2020

Gastric Adenocarcinoma, Metastatic Gastric Cancer, Metastatic Adenocarcinoma Trial in France (Atezolizumab + Ipatasertib,

Recruiting
  • Gastric Adenocarcinoma
  • +3 more
  • Atezolizumab + Ipatasertib
  • Atezolizumab + Bevacizumab
  • Dijon, France
  • +8 more
Mar 26, 2021

Lung Tumor Malignant, Interstitial Lung Disease Trial in Warszawa (Prolonged glucocorticosteroid (prednisone) regimen, Short

Unknown status
  • Lung Neoplasm Malignant
  • Interstitial Lung Disease
  • Prolonged glucocorticosteroid (prednisone) regimen
  • Short glucocorticosteroid (prednisone) regimen
  • Warszawa, Mazowieckie, Poland
    Instutut Gruzlicy I Chorob Pluc
Feb 26, 2020

Extensive-stage Small Cell Lung Cancer, Radiotherapy, Immunotherapy Trial in Beijing (PD-1 inhibitor JS-001)

Unknown status
  • Extensive-stage Small Cell Lung Cancer
  • +2 more
  • PD-1 inhibitor JS-001
  • Beijing, Beijing, China
    Cancer Insititute and Hosiptal of Chinese Academy of Medical Sci
Jun 2, 2019

Cardiopulmonary Arrest With Successful Resuscitation Trial (CPR self-training)

Completed
  • Cardiopulmonary Arrest With Successful Resuscitation
  • CPR self-training
  • (no location specified)
Oct 31, 2018

Metastatic Melanoma, Head Neck Cancer Trial in Worldwide (SD-101(1), Pembrolizumab, SD-101(2))

Terminated
Has Results
  • Metastatic Melanoma
  • Head Neck Cancer
  • Birmingham, Alabama
  • +46 more
Jul 12, 2021

NSCLC, Drug-Related Side Effects and Adverse Reactions Trial in Brussels (Consultation of the patient's medical files at the

Completed
  • Carcinoma, Non-Small-Cell Lung
  • Drug-Related Side Effects and Adverse Reactions
  • Consultation of the patient's medical files at the hospital
  • Brussels, Belgium
    Cliniques Universitaires Saint-Luc
Feb 17, 2019

NSCLC Trial in Goodyear (Pembrolizumab, Acalabrutinib)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Goodyear, Arizona
    Western Regional Medical Center/Cancer Treatment Center of Ameri
Aug 22, 2019

Small Cell Lung Cancer Trial in Saint Louis Park, Columbus (Topotecan, Pembrolizumab)

Active, not recruiting
  • Small Cell Lung Cancer
  • Saint Louis Park, Minnesota
  • +1 more
Jul 29, 2019

NSCLC Stage IIIB, NSCLC Stage IV, EGFR Activating Mutation Trial in Hong Kong (Atezolizumab, Bevacizumab, Carboplatin)

Unknown status
  • NSCLC Stage IIIB
  • +2 more
  • Hong Kong, Hong Kong
    Department of Clinical Oncology
Apr 16, 2019

Advanced or Metastatic Melanoma, Advanced or Metastatic NSCLC Trial in France (immune-checkpoint inhibitors therapies)

Unknown status
  • Advanced or Metastatic Melanoma
  • Advanced or Metastatic NSCLC
  • immune-checkpoint inhibitors therapies
  • Marseille, Bouches Du Rhône, France
  • +8 more
Sep 25, 2019

Tumor, Solid, Lymphoma Trial in Beijing (GR1405 injection)

Unknown status
  • Tumor, Solid
  • Lymphoma
  • GR1405 injection
  • Beijing, China
    Cancer Institute/Hospital, Chinese Academy of Medical Sciences &
Nov 4, 2018

Immune Checkpoint Inhibitors for Advanced Gastric Cancer

Unknown status
  • Gastric Cancer
    • Guangzhou, Guangdong, China
    • +1 more
    Sep 11, 2019

    Effect of Chemotherapy on PD-L1 in NSCLC

    Unknown status
    • Chemotherapy
    • +2 more
    • PD-L1 group
    • Shanghai, Shanghai, China
      Shanghai Changzheng Hospital
    Oct 8, 2018

    Effect of Chemotherapy on TMB in NSCLC

    Unknown status
    • Chemotherapy Effect
    • +3 more
    • Next-Genernation Sequence
    • Shanghai, Shanghai, China
      Shanghai Changzheng Hospital
    Sep 23, 2018

    Melanoma Trial (Pembrolizumab)

    No longer available
    • Melanoma
    • Pembrolizumab
    • (no location specified)
    Jan 25, 2018

    Carcinoma, Non-small Cell Lung Trial in Spain, United States (Abemaciclib, Pemetrexed, Gemcitabine)

    Completed
    Has Results
    • Carcinoma, Non-small Cell Lung
    • Fayetteville, Arkansas
    • +10 more
    Aug 22, 2020

    ALK-positive Advanced NSCLC Trial in United States (Crizotinib, Pembrolizumab)

    Terminated
    Has Results
    • ALK-positive Advanced NSCLC
    • Birmingham, Alabama
    • +14 more
    Apr 4, 2019

    Melanoma, NSCLC, Squamous Cell Carcinoma of the Head and Neck Trial in United States (PLX3397, Pembrolizumab)

    Terminated
    Has Results
    • Melanoma
    • +4 more
    • Scottsdale, Arizona
    • +11 more
    Feb 18, 2020

    Intergenerational Relations, Loneliness, Identity, Social Trial in Singapore (ARTISAN)

    Unknown status
    • Intergenerational Relations
    • +2 more
    • ARTISAN
    • Singapore, Singapore
      Nanyang Technological University
    Jul 10, 2018

    NSCLC Trial (Durvalumab, Tremelimumab)

    Withdrawn
    • Non-small Cell Lung Cancer
    • (no location specified)
    Dec 4, 2017

    Carcinoma, Small Cell Lung Trial (BEC2 Vaccine)

    Completed
    • Carcinoma, Small Cell Lung
    • BEC2 Vaccine
    • (no location specified)
    Apr 7, 2010